These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 17890728)

  • 1. Improving the quality of anticoagulant therapy in patients with mechanical heart valves: what are we waiting for?
    Herijgers P; Verhamme P
    Eur Heart J; 2007 Oct; 28(20):2424-6. PubMed ID: 17890728
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II.
    Koertke H; Zittermann A; Tenderich G; Wagner O; El-Arousy M; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Koerfer R
    Eur Heart J; 2007 Oct; 28(20):2479-84. PubMed ID: 17890730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose oral anticoagulation therapy in mechanical heart valve prostheses: the Italian experience.
    Di Nucci GD
    J Heart Valve Dis; 2004 May; 13 Suppl 1():S86-7. PubMed ID: 15225013
    [No Abstract]   [Full Text] [Related]  

  • 4. High complication and failure rates of anticoagulant therapy are unavoidable.
    Nitter-Hauge S; Dale J
    Z Kardiol; 1986; 75 Suppl 2():293-7. PubMed ID: 3727705
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral anticoagulation in patients with mechanical valve prostheses: evolving protocols with new generation devices.
    Cotrufo M; De Feo M; De Santo LS; Della Corte A; Scardone M; Costanza S
    Ital Heart J; 2005 May; 6(5):401-4. PubMed ID: 15934413
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulation is necessary in all patients with mechanical prostheses in sinus rhythm.
    Duveau D
    Z Kardiol; 1986; 75 Suppl 2():326-31. PubMed ID: 3727712
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors for bleeding in patients taking coumarins.
    Beyth RJ; Milligan PE; Gage BF
    Curr Hematol Rep; 2002 Sep; 1(1):41-9. PubMed ID: 12901124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing thromboembolism in patients with prosthetic heart valves.
    Turpie AG
    Cardiol Clin; 1994 Aug; 12(3):487-93. PubMed ID: 7805081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The preparation of a patient with long-term anticoagulant cumarin treatment for invasive surgery].
    Penka M; Buliková A; Gumulec J; Matýsková M; Smejkal P; Kissová J; Slechtová M; Chlupová G
    Vnitr Lek; 2006 Mar; 52 Suppl 1():35-40. PubMed ID: 16637448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dental extractions in patients maintained on oral anticoagulant therapy: comparison of INR value with occurrence of postoperative bleeding.
    Blinder D; Manor Y; Martinowitz U; Taicher S
    Int J Oral Maxillofac Surg; 2001 Dec; 30(6):518-21. PubMed ID: 11829234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticoagulation by oral treatment with vitamin K antagonists].
    Kemkes-Matthes B
    Hamostaseologie; 2008 Dec; 28(5):421-7. PubMed ID: 19132171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Low INR-levels in certain mechanical heart valves?].
    Wittwer T
    Dtsch Med Wochenschr; 2010 Feb; 135(8):366. PubMed ID: 20166003
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anticoagulant treatment of patient with the substitute heart valve].
    Halinen MO; Lassila R
    Duodecim; 2000; 116(2):157-65. PubMed ID: 11764475
    [No Abstract]   [Full Text] [Related]  

  • 14. A practical approach for bridging anticoagulation after mechanical heart valve replacement.
    Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G
    J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of anticoagulant therapy.
    Ellison N; Jobes DR; Schwartz AJ
    Int Anesthesiol Clin; 1982; 20(4):121-35. PubMed ID: 6757142
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimal target international normalized ratio for patients with mechanical heart valves.
    Takkenberg JJ; Puvimanasinghe JP; van Herwerden LA
    J Am Coll Cardiol; 2004 Sep; 44(5):1142-3; author reply 1144-5. PubMed ID: 15337235
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anticoagulant prophylaxis in alloplastic cardiac valve implants].
    Neef H; Wenzel KP
    Dtsch Gesundheitsw; 1971 Feb; 26(6):253-6. PubMed ID: 5095599
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue.
    Colli A; Verhoye JP; Leguerrier A; Gherli T
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):573-7. PubMed ID: 17317197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of low molecular weight heparin in pregnant women with mechanical heart valves.
    Yinon Y; Siu SC; Warshafsky C; Maxwell C; McLeod A; Colman JM; Sermer M; Silversides CK
    Am J Cardiol; 2009 Nov; 104(9):1259-63. PubMed ID: 19840573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of oral anticoagulation for patients with mechanical heart valve prostheses.
    Piper C; Schulte HD; Horstkotte D
    J Heart Valve Dis; 1995 Mar; 4(2):127-37. PubMed ID: 8556172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.